179 related articles for article (PubMed ID: 19258540)
41. Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials.
Bonovas S; Fiorino G; Lytras T; Malesci A; Danese S
World J Gastroenterol; 2016 May; 22(18):4594-603. PubMed ID: 27182169
[TBL] [Abstract][Full Text] [Related]
42. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
Huls G; Koornstra JJ; Kleibeuker JH
Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
[TBL] [Abstract][Full Text] [Related]
43. Randomized phase II trial of sulindac for lung cancer chemoprevention.
Limburg PJ; Mandrekar SJ; Aubry MC; Ziegler KL; Zhang J; Yi JE; Henry M; Tazelaar HD; Lam S; McWilliams A; Midthun DE; Edell ES; Rickman OB; Mazzone P; Tockman M; Beamis JF; Lamb C; Simoff M; Loprinzi C; Szabo E; Jett J;
Lung Cancer; 2013 Mar; 79(3):254-61. PubMed ID: 23261228
[TBL] [Abstract][Full Text] [Related]
44. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.
DuBois RN; Giardiello FM; Smalley WE
Gastroenterol Clin North Am; 1996 Dec; 25(4):773-91. PubMed ID: 8960892
[TBL] [Abstract][Full Text] [Related]
45. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.
Koornstra JJ; Rijcken FE; Oldenhuis CN; Zwart N; van der Sluis T; Hollema H; deVries EG; Keller JJ; Offerhaus JA; Giardiello FM; Kleibeuker JH
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1608-12. PubMed ID: 16030090
[TBL] [Abstract][Full Text] [Related]
46. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
[TBL] [Abstract][Full Text] [Related]
47. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
[TBL] [Abstract][Full Text] [Related]
48. Chemoprevention of colorectal cancer: slow, steady progress.
Burke CA; Bauer WM; Lashner B
Cleve Clin J Med; 2003 Apr; 70(4):346-50. PubMed ID: 12701989
[TBL] [Abstract][Full Text] [Related]
49. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer.
Love RR; Jacoby R; Newton MA; Tutsch KD; Simon K; Pomplun M; Verma AK
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):989-92. PubMed ID: 9829706
[TBL] [Abstract][Full Text] [Related]
50. Differential preventive activity of sulindac and atorvastatin in Apc
Chang WL; Jackson C; Riel S; Cooper HS; Devarajan K; Hensley HH; Zhou Y; Vanderveer LA; Nguyen MT; Clapper ML
Gut; 2018 Jul; 67(7):1290-1298. PubMed ID: 29122850
[TBL] [Abstract][Full Text] [Related]
51. PACES trial: Evaluating the effectiveness of eflornithine and sulindac in preventing colon adenomas.
Zell J; You YN; Boughey JC
Bull Am Coll Surg; 2015 Aug; 100(8):70-1. PubMed ID: 26419059
[No Abstract] [Full Text] [Related]
52. Randomized double-blind trial of sulindac and etodolac to eradicate aberrant crypt foci and to prevent sporadic colorectal polyps.
Takayama T; Nagashima H; Maeda M; Nojiri S; Hirayama M; Nakano Y; Takahashi Y; Sato Y; Sekikawa H; Mori M; Sonoda T; Kimura T; Kato J; Niitsu Y
Clin Cancer Res; 2011 Jun; 17(11):3803-11. PubMed ID: 21385928
[TBL] [Abstract][Full Text] [Related]
53. Sulindac and polyp regression.
Giardiello FM
Cancer Metastasis Rev; 1994 Dec; 13(3-4):279-83. PubMed ID: 7712590
[TBL] [Abstract][Full Text] [Related]
54. Adherence assessment using medication weight in a phase IIb clinical trial of difluoromethylornithine for the chemoprevention of skin cancer.
Hess LM; Saboda K; Malone DC; Salasche S; Warneke J; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2579-83. PubMed ID: 16284381
[TBL] [Abstract][Full Text] [Related]
55. Celecoxib for the prevention of colorectal adenomatous polyps.
Arber N; Eagle CJ; Spicak J; Rácz I; Dite P; Hajer J; Zavoral M; Lechuga MJ; Gerletti P; Tang J; Rosenstein RB; Macdonald K; Bhadra P; Fowler R; Wittes J; Zauber AG; Solomon SD; Levin B;
N Engl J Med; 2006 Aug; 355(9):885-95. PubMed ID: 16943401
[TBL] [Abstract][Full Text] [Related]
56. Drugs to prevent colon cancer show promise, but hurdles remain for chemoprevention.
Tuma R
J Natl Cancer Inst; 2008 Jun; 100(11):764-6. PubMed ID: 18505958
[No Abstract] [Full Text] [Related]
57. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.
Rostom A; Dubé C; Lewin G; Tsertsvadze A; Barrowman N; Code C; Sampson M; Moher D;
Ann Intern Med; 2007 Mar; 146(5):376-89. PubMed ID: 17339623
[TBL] [Abstract][Full Text] [Related]
58. Phase IIB Randomized Study of Topical Difluoromethylornithine and Topical Diclofenac on Sun-Damaged Skin of the Forearm.
Jeter JM; Curiel-Lewandrowski C; Stratton SP; Myrdal PB; Warneke JA; Einspahr JG; Bartels HG; Yozwiak M; Bermudez Y; Hu C; Bartels P; Alberts DS
Cancer Prev Res (Phila); 2016 Feb; 9(2):128-34. PubMed ID: 26712942
[TBL] [Abstract][Full Text] [Related]
59. Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats.
Madka V; Patlolla JMR; Venkatachalam K; Zhang Y; Pathuri G; Stratton N; Lightfoot S; Janakiram NB; Mohammed A; Rao CV
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568816
[TBL] [Abstract][Full Text] [Related]
60. The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine.
Xie G; Nie T; Mackenzie GG; Sun Y; Huang L; Ouyang N; Alston N; Zhu C; Murray OT; Constantinides PP; Kopelovich L; Rigas B
Br J Pharmacol; 2012 Apr; 165(7):2152-66. PubMed ID: 21955327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
